Rich Pharmaceuticals Announces Collaboration Agreement To Support The Development of Treatments For Parkinson's Disease
BEVERLY HILLS, CA--(Marketwired - Jul 18, 2017) - Rich Pharmaceuticals, Inc. (OTC PINK: RCHA), a biopharmaceutical company focused on developing and commercializing innovative therapies in oncology, today announced that it has signed a support and …